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Micronuclei (MN) are extra-nuclear bodies that contain damaged chromosome fragments
and/or whole chromosomes that were not incorporated into the nucleus after cell division.
MN can be induced by defects in the cell repair machinery and accumulation of DNA
damages and chromosomal aberrations. A variety of genotoxic agents may induce MN
formation leading to cell death, genomic instability, or cancer development. In this
review, the genetic and epigenetic mechanisms of MN formation after various clastogenic
and aneugenic effects on cell division and cell cycle are described. The knowledge
accumulated in literature on cytotoxicity of various genotoxins is precisely reﬂected and
individual sensitivity to MN formation due to single gene polymorphisms is discussed.The
importance of rapid MN scoring with respect to the cytokinesis-block micronucleus assay
is also evaluated.
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INTRODUCTION
Micronuclei (MN), also known as Howell–Jolly bodies, were ﬁrst
identiﬁed at the end of nineteenth century in red cell precursors
by William Howell, an American, and Justin Jolly, a Frenchman
(Sears and Udden, 2011). At that time, Howell–Jolly bodies were
described as remnants of nuclei of red blood cells circulating in
organs with pathological features (Sears and Udden, 2011). The
signiﬁcance of MN was evaluated in the mid-twentieth century.
Dawson and Bury (1961) found MN in red cells within the bone
marrow during different pathological states. The authors also
mentioned that the formation of Howell–Jolly bodies was paral-
leled with folic acid and vitamin B deﬁciency (Dawson and Bury,
1961). Not so long after, MN were described in other cells, mainly
lymphocytes. Irradiation of lymphocytes in vitro caused a linear
relationship between the dose and micronucleus induction. In
the same study, the micronucleus technique was proposed as a
reliable method for measuring chromosomal damages caused by
cytotoxic agents “in vivo” (Fenech and Morley, 1985). Scoring of
MN in cytokinesis-blocked binucleated cells after treatment with
cytochalasin-B (Cyt-B) was postulated as a procedure of choice
(Fenech and Morley, 1985).
Because the incidence of MN in peripheral blood erythrocytes
of splenectomized patients rose after chemotherapy, scoring of
MN in such cells was proposed in order to monitor clastogenics
exposure in individuals (Schlegel et al., 1986). The belief that MN
were sensitive biomarkers of genotoxicity was conﬁrmed by devel-
opment of recommended protocols, scoring methods, dose levels,
choice of species, sex differences, in vivo and cell culture assays,
and statistical considerations (Heddle et al., 1983).
The importance of scoringMNproduced by the action of geno-
toxic agents was emphasized by many cytogeneticists. A simple
Giemsa stain was initially used for MN staining followed by slide
scoring (Countryman and Heddle, 1976). Later, a cytokinesis-
block micronucleus (CBMN) method was reported, where Cyt-B,
an inhibitor of the spindle assembly, was used to prevent cyto-
plasmic division after nuclear division had occurred (Fenech and
Morley, 1986). The CBMN assay was proven to be more efﬁ-
cient in studying X-ray-induced chromosomal aberrations than
other methods, including incorporating of bromodeoxyuridine
(Ramalho et al., 1988). It was solely used for the assessment of
chromosomal loss, breakage, and associated apoptosis and necro-
sis induced by different mutagens, for instance, hydrogen peroxide
(Fenech et al., 1999). The main advantage of the test is its ability
to differentiate MN formed as a result of clastogenic or/and aneu-
genic treatment. Blocking dividing cells at the binucleated stage,
makes it possible to recognize chromosomal loss, chromosomal
breakage, and nucleoplasmic bridges (NPBs). The latter disap-
pear after cytokinesis if the cell is allowed to divide (Thomas et al.,
2003).
The CBMN method allows accumulating virtually all cells at
the binucleate stage regardless of their division kinetics, thus mak-
ing the test highly sensitive. In his review, Fenech (2000) precisely
described the in vitro technique, including detailed protocols and
criteria for scoring MN. The test is also used for scoring MN in
cultured lymphocytes from subjects previously exposed to geno-
toxins, however, it is unclear if such MN originated in vivo or ex
vivo during cell culture. Therefore, Speit et al. (2011) proposed
an additional scoring of MN, 24 h after starting cell culture when
lymphocytes are still mononuclear.
Recognizing centromere and kinetochore sites in MN may
further increase the speciﬁcity of the technique. Lagging chro-
mosomes can be recognized by anti-kinetochore antibodies
in CREST treatment (scleroderma Calcinosis, Raynaud’s phe-
nomenon, Esophageal dysmotility, Sclerodactyly, and Telang-
iectasia). Alternatively, centromeric regions can be detected by
FISH (ﬂuorescence in situ hybridization; Mateuca et al., 2006).
Centromere and kinetochore negative MN are considered to con-
tain acentric fragments. CREST, FISH, and chromosome-speciﬁc
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probes allow detecting the non-random, but rather prevalent
existence of speciﬁc chromosomes and fragments in MN. For
instance, it was shown, that the X chromosome tends to lag behind
in anaphase and is more often micronucleated than autosomes.
Among autosomes, the most prevalent in MN are chromosomes
9, 1, and 16 due to the breakage in heterochromatic sites in these
chromosomes (Norppa and Falck, 2003).
Today, numerous studies include micronucleus scoring for
measuring DNA lesions and genotoxicity of almost any possi-
ble chemical and radioactive compound (Lau et al., 2009; Watters
et al., 2009; Cveticanin et al., 2010; Lal and Ames, 2011). The
results obtained by such methods are comparable with those of
H2AX phosphorylation and comet assays. For instance, γ-H2AX
phosphorylation in immortalized mouse embryonic ﬁbroblasts
treated with etoposide (an inhibitor topoisomerase II), methyl
methanesulfonate (MMS; an alkylating agent) and bleomycin (a
DNA damage agent) was increased in the dose–response relation-
ship. The Comet assay showed similar trend during this study.
The same increase in micronucleus events was also observed dur-
ing all genotoxic treatments (Watters et al., 2009). Micronucleus
frequency was shown to be correlated with DNA double-strand
breaks (DSBs) and DNA recombination events in hematopoietic
tissues of fetal mice after in utero exposure to benzene. Benzene
is known to be a human leukomogen and such events may be
the primary steps for the development of childhood leukemias
(Lau et al., 2009). The inﬂuence of the micronutrient deﬁciency
on MN formation and the initiation of hematological diseases
was also shown. Therefore, understanding the link between the
micronutrient status and MN frequency may be useful for the
future development of novel therapeutic approaches (Lal and
Ames, 2011).
It is not surprising that the micronucleus assay is also used
for genotoxicity screening of new and promising applications in
biology, medicine, and nanotechnology. For instance, genotoxic
properties of carbon nanotubes which are used in electrical cir-
cuits, paper batteries, solar panels, as well as inmedicine for cancer
treatment can induce micronucleus formation and DNA DSBs in
lymphocytes (Cveticanin et al., 2010). MN might induce DNA
damage response (DDR). Terradas et al. (2009) described the local
induction of the DDR in MN displaying γ-H2AX foci after γ-
ray treatment. The existence of DSBs in MN is not surprising as
MN are the products of DNA damage, but the initiation of DDR
is controversial as MN do not contain DNA repair machinery.
According to Terradas et al. (2012), the micronuclear envelope
structure determines whether recruited repair factors can reach
MN chromatin.
MICRONUCLEI FORMATION
Micronuclei are tiny extra-nuclear bodies originating from
acentric chromatid/chromosome fragments or whole chro-
matids/chromosomes that lag behind at the anaphase of dividing
cells and are not included in the main nucleus during telophase
(Figures 1 and 2). Instead, they are enwrapped by the nuclear
membrane and resemble the structure of the daughter nucleus,
althoughbeingway smaller in size (Sedelnikova et al., 2007; Fenech
et al., 2011). Acentric chromatid/chromosome fragments usu-
ally originate after extensive DNA damage such as DSBs that if
FIGURE 1 | Image of micronucleated cells in the artificial human 3D
Air-100 epithelial tissue. Nuclei and micronuclei are stained with
propidium iodide (red). Micronuclei positive for γ-H2AX present green. Blue
outline, micronucleated cells. White arrows, micronuclei positive for
γ-H2AX; yellow arrow, a micronucleus without γ-H2AX staining. Adopted
with permission from Sedelnikova et al. (2007).
misrepaired result in asymmetrical chromosome rearrangements
and exchanges. Whole chromatids or chromosomes in MN are
formed due to deﬁciencies in chromosome segregation during
anaphase usually caused by mitotic spindle failure, kinetochore
damage, centromeric DNA hypomethylation, and defects in the
cell cycle control system (Mateuca et al., 2006).
To form an acentric fragment, DNA DSBs should either occur
in one sister chromatid or extend to the whole anaphase chromo-
some (Figure 3). This happens only if the level of DSBs exceeds the
repair capacity of dividing cells, which is mainly due to either the
misrepair of DSBs by the dysfunctional homologous recombina-
tion (HR;O’Donovan and Livingston, 2010) or defects in enzymes
of the non-homologous end-joining (NHEJ) pathway (Hartlerode
and Scully, 2009). The formation of DNA DSBs and MN is often
the result of simultaneous excision repair of damages and wrong
base incorporation. A failure of the appropriate gap-ﬁlling event
leads to DSB (Dianov et al., 1991).
Malsegregation of sister chromatids usually happens due to the
absence or inappropriate attachment of spindle microtubules to
chromosome kinetochores (Cimini and Degrassi, 2005). Stable
amphitelic microtubule attachments generate tension at kine-
tochores, locking the correct chromatid orientation in place.
Unstable microtubule–kinetochore attachments such as syntelic
(both sister chromatids are attached to the same spindle pole),
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FIGURE 2 | Micronucleus formation in the cell exposed to genotoxic agent.
monotelic (only one kinetochore is attached leaving the second
sister chromatid unattached), or merotelic (one kinetochore is
attached to both spindle poles) do not result in signiﬁcant tension,
thus making the bond sensitive to dissociation (Figure 3). If not
corrected, such attachments lead to inappropriate segregation and
chromosome loss, thus resulting in aneuploidy and micronucleus
formation, respectively (Figure 4).
According to Fenech et al. (2011), the main mechanism of
MN formation originated from chromosome malsegregation is
hypomethylation of centromeric and paracentromeric regions –
satellite repeats. Usually, satellites are hypermethylated, and loss
of methylation elongates repeat regions decreasing the tension in
kinetochores and thus creatingwrong connections betweenmicro-
tubules of the mitotic spindle and chromosomes (Fenech et al.,
2011). Sometimes, chromatids/chromosomes are unable to segre-
gate as the mitotic spindle cannot pull them apart due to tubulin
depolymerization. The absence of kinetochore or centromeric
defects also lags chromosomes behind at telophase (Figure 3).
Nucleoplasmic bridges and nuclear buds (NBUDs) are similar
to MN (Fenech et al., 2011). NPBs originate from dicentric chro-
mosomes – ones that have two centromeric regions. Dicentrics are
products of either HR between complementary DNA sequences
of different chromosomes or NHEJ between two chromosomes
that suffer from DNA DSBs (Obe et al., 2002). Similarly to the lat-
ter, NHEJ can be recruited to improperly encapsulated telomeres
during their shortening. If a 3′ single-stranded overhang at the
telomere is not properly capped, it is recognized as a broken DNA
molecule which should be fused by NHEJ mechanism (Tarsounas
andWest, 2005; Longhese, 2008).
Having two centromeres, a dicentric chromosome may attach
to two opposite spindle bodies which pull chromatids in the oppo-
site directions. In the absence of breakage, the nuclear membrane
surrounds both nuclei forming NPBs between them. Eventually,
NPB is broken during cytokinesis, resulting in a micronucleus
formation (Figure 3; Fenech et al., 2011). Misrepair of two chro-
mosomal breaks causes the formation of both dicentric and
acentric fragments. The latter will formMN of its own (Figure 3).
Telomere fusion results in NPB that after breakage will accompany
one of the daughter nuclei in the form of MN. MN and NPBs
formed after telomere fusion contain telomeric sequences which
can be recognized by speciﬁc probes that hybridize to subtelom-
eric regions (Boukamp et al., 2005). In contrast, MN and NPBs
originated from DSBs misrepair are telomere negative (Fenech,
2007).
Anaphase bridges are initial events in breakage-fusion-bridge
(BFB) cycles which are the features of chromosomal instability.
Theunevenbreakage of NPBs leads to the formationof twodaugh-
ter nuclei, one of which gained extra genetic information, whereas
the second one lost an equal amount of genetic information. Such
broken chromosomes usually do not contain telomeric zones and,
therefore, can fuse with their replica during the next mitotic event,
repeating the cycle for the next couple rounds. BFB cycles lead to
the ampliﬁcation of genes near the break point which are eventu-
ally looped out of the abnormal chromosome, thus forming the
so-called doubleminutes (DMs). DMchromosomes are selectively
located at the periphery of the nucleus and are eliminated from the
nucleus by nuclear budding during S phase (Shimizu et al., 1998).
A NBUD is virtually the same as a micronucleus, except for its
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FIGURE 3 | Mechanisms of formation of MN containing acentric
fragments, chromatids, and chromosomes as a result of DSBs, due
to an unstable microtubule–kinetochore attachment, tubulin
depolymerization, or kinetochore loss, breakage-fusion-bridge
cycles, and the elimination of amplified genes through nuclear
budding.
closer location and connection to the nucleus through a narrow
cytoplasmic passage. NBUD also contains interstitial or terminal
fragments without centromeric or telomeric regions, whereas MN
is formed from a lagging chromosome (Dutra et al., 2010).
While brieﬂy summarizing the mechanisms of MN forma-
tion, it is important to emphasize that MN containing acen-
tric chromatids or chromosomes are the result of unrepaired
or misrepaired DNA breaks, whereas MN with whole chro-
matids/chromosomes are formed due to (a) hypomethylation of
satellite centromeric/paracentromeric sequences, (b) kinetochore
defects, (c) dysfunctional spindle, and (d) mutations in anaphase
checkpoint genes (Figure 3). NPBs originate from misrepaired
DNA breaks, telomere end fusion, or failure of sister chromatids
to separate due to the lack of decatenation. Last but not least,
nuclear budding occurs as a result of either elimination of ampli-
ﬁed DNA resulted through BFB cycles or speciﬁc elimination of
excess chromosomes in polyploidy cells (Wang et al., 2004).
ROLE OF EPIGENETICS IN MICRONUCLEI FORMATION
Understanding of the mechanisms of MN formation induced by
genotoxic agents is of a great signiﬁcance for both the detection
of diseases such as cancer and their treatment. The manipulation
of such mechanisms may be beneﬁcial for both the prevention of
MN formation and development of diseases and the induction of
MN for therapeutic purposes. In fact, it is a matter of choosing the
right target in the process of MN formation.
Epigenetics has recently become a very promising target for
manipulation in molecular biology because of the growing evi-
dence of its involvement in chromatin status regulation, gene
expression; and both epigenetics and genetics have an equal inﬂu-
ence on the development of genomic instability and cancer (Aypar
et al., 2011). The greatest potential of epigenetic alterations is their
reversible nature in contrast to mutations which made epigenetics
so attractive for therapeutic research.
The initial understanding of epigenetics proposed byWadding-
ton reﬂected a model of gene interaction with their surroundings.
Depending on a gene and its surrounding, such interaction
produced a speciﬁc phenotype. Nowadays, epigenetics is rather
deﬁned as a memory of stable changes in gene expression without
changes in gene sequence, and such memory can be passed on to
progeny (Jiang et al., 2008). Such memory explains differences
between genetically identical cells in a multicellular organism.
Thus, gene expression in functionally different cells is epigenet-
ically regulated. The ability of cells to change gene expression
without altering gene sequence not only allows for maintain-
ing tissue identity but also gives a possibility for the adaptation
to a changing environment, should such changes occur (Jirtle
and Skinner, 2007). Because transcription requires the cooper-
ative effort of chromatin, the protein complexes that modify
chromatin structure and transcription factors, the objective of
epigenetics is to ﬁnd out how both the genetic code in the
DNA sequence and the way that the DNA is packaged control
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FIGURE 4 | Role of chromosome mis-segregation in micronuclei formation (modified after Cimini and Degrassi, 2005 with permission).
gene expression (Bock and Lengauer, 2008). The contribution
of epigenetic alterations to MN formation is now clearly evi-
dent, and research on the epigenetic mechanisms involved in MN
is growing. Epigenetic regulation includes at least four outlined
mechanisms: DNA methylation, histone modiﬁcations, chro-
matin remodeling, and non-coding RNA expression (Bonasio
et al., 2010; Gibney and Nolan, 2010). DNA methylation was
discovered ﬁrst and, therefore, is the most extensively studied.
It is the only epigenetic mechanism that directly targets DNA.
A methyl group replaces a hydrogen atom in the cytosine base
of DNA, thus creating a new covalent bond. Such modiﬁcation
happens predominantly in cytosine-phosphate-guanine (CpG)-
dinucleotides (Bird, 2009). The addition of a methyl group does
not affect the transcription of cytosine, but it alters chromatin
in a way such that to interfere with and reduce DNA-binding
capacities of transcription factors (Weber and Schubeler, 2007).
Methyl-CpG-bindingproteins (MBPs) recruit transcriptional sup-
pressors to modify chromatin (Fujita et al., 2003; Kondo et al.,
2005). Enzymes that methylate DNA are DNA methyltrans-
ferases: DNMT1, DNMT2, DNMT3a, and DNMT3b. DNMT1
can maintain a DNA methylation pattern by reading and faith-
fully copying it from an old DNA strand to a newly synthesized
strand during replication. DNMT3a and b target unmethylated
CpG sites for de novo methylation in embryonic stem cells and
cancer cells (Okano et al., 1999). Such methylation activity is
important for the establishment of parental imprints (Kato et al.,
2007). DNMT2 has been shown to methylate tRNA (Goll et al.,
2006) in addition to a weak methyltransferase activity in vitro
(Hermann et al., 2003).
The role of DNA methylation is crucial for normal develop-
ment, proliferation, and genome stability. The distribution of
CpG-dinucleotides is not random in the genome. Most of CpG
sites are clustered in promoter areas of genes creating so-called
CpG islands (Bird, 2009). Usually, promoters of tumor sup-
pressor genes are hypomethylated to allow their expression for
normal functioning of cells (Herman and Baylin, 2003), whereas
oncogenes and some repeat elements are silenced through hyper-
methylation, thus maintaining genome integrity (Huang et al.,
2004). Reanimated transposons can lead to translocations, gene
disruption, and chromosomal instability (Bestor, 2005). X chro-
mosome inactivation is also a result of hypermethylation (Reik
and Lewis, 2005). Centromeric regions of chromosomes are
heterochromatic and lay within tandemly repeated DNA. Consti-
tutive heterochromatin of centromeres is epigenetically silenced by
histone methylation (H3K9Me3 and H3K27Me) and DNA hyper-
methylation, thus enabling a low frequency of recombination and
the repression of transcription (Peters et al., 2003; Grunau et al.,
2006). However, undermethylation of repeated DNA sequences
and satellite DNA in the centromeric and pericentromeric regions
of chromosomes is highly linked to karyotypic instability found
in a variety of cancers (Ehrlich, 2002). The possibility exists that
DNA hypomethylation in the centromeric region may modify a
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platform for the correct kinetochore orientation and attachment
to the spindle, resulting in improper chromosome segregation and
MN formation. Such hypothesis is mainly supported by ongo-
ing experiments involving DNA methylation activators/inhibitors
which affect MN formation. For instance, treatment of human
ﬁbroblasts with S-adenosyl-methionine (SAM) reduces the fre-
quency of MN caused by sodium arsenite (NaAsO2; Ramirez et al.,
2007). The genotoxicity of arsenic is characterized by the gener-
ation of free radicals, changes in DNA methylation patterns, the
inhibition of DNA repair and formation of MN. Interestingly, in
this study, SAM decreased arsenic-induced MN containing only
whole chromosomes but not fragments. This means that SAM
may prevent chromosome loss and aneuploidy, but it is not capa-
ble of reducing chromosome breaks and clastogenicity. According
to the authors, NaAsO2 is a demethylating agent whichmay possi-
bly disturb chromatin condensation in the pericentromeric region
affecting the correct kinetochore orientation and attachment to
the spindle; and SAM, as a methyl group donor, may correct
chromosome alignment and segregation (Ramirez et al., 2007).
Another possible explanation relied on SAM as a potent antioxi-
dant agentwhichmayprevent the oxidative stress causedby arsenic
compounds, but in such case, a decrease in DNA DSBs would
be expected, yet it did not happen. The data of the study sup-
ported the idea that SAMprotects chromosome segregation by the
restoration of DNA methylation status, preventing MN induction
(Ramirez et al., 2007). In one of the earlier studies on lymphocyte
cultures, the authors demonstrated that 5-azacytidine induced
a signiﬁcant undercondensation of heterochromatic regions of
chromosomes 1, 9, 15, 16, andY which correlated with an increase
in MN formation (Guttenbach and Schmid, 1994). The study
showed that the chromosome that was most frequently elimi-
nated in MN was chromosome 1 (41%). Undercondensation of
heterochromatin in chromosome 1 was the most frequent event
(52% of metaphases). In contrast, chromosomes 11, 17, and X
contained 5-azacytidine-resistant heterochromatin and were not
included in MN formation (Guttenbach and Schmid, 1994). A
year later, Stopper et al. (1995) demonstrated MN induction by
four analogs of cytidine: 5-ﬂuoro-2′-deoxycytidine, 5,6-dihydro-
5-azacytidine, 5-azacytidine and 6-azacytidine. All four analog
induced MN, but the lack of kinetochore staining in most of
MN indicated that the compoundswere clastogenic (Stopper et al.,
1995). 5-Azacytidine functions as an inhibitor of DNMTs which
recognizes the analog as the natural substrate in the methylation
reaction, thus becoming trapped and degraded (Stresemann et al.,
2006). A recent study indicates that global DNA hypomethyla-
tion correlates with MN formation, increased ploidy and DNA
damage in equine sarcoid-derived ﬁbroblasts affected by bovine
papillomavirus (BPV-1; Potocki et al., 2012). A similar correlation
between MN induction and DNA hypomethylation was shown in
radiation-induced bystander cells. An increase in the level of MN,
DNA DSBs, and apoptosis was parallel to the loss of nuclear DNA
methylation in bystander human cells after microbeam radiation
(Sedelnikova et al., 2007).
Furthermore, recent studies show association between folate
levels and MN. Folate is an important B group vitamin that
partakes in a complex homocysteine cycle which yields SAM –
a key methyl donor for DNA methyltransferases (Fuso, 2013).
Therefore, folate is crucially important for DNA methylation.
Recent studies have shown that folate deﬁciency is associated with
genomic damage and formation of MN and other nuclear abnor-
malities in human lymphocytes (Bull et al., 2012; Lu et al., 2012).
Furthermore, folate supplementation led to a pronounced reduc-
tion in DNA damage and MN formation (Lazalde-Ramos et al.,
2012). These data provide additional support to the epigenetic
mechanisms of MN formation.
Based on all the aforementioned facts and lines of evidence, we
may conclude thatMN formation is induced epigeneticallymainly
through the loss of DNA methylation. Speciﬁcally, hypomethyla-
tion of heterochromatin in the pericentromeric regions is asso-
ciated with chromatin decondensation, which leads to improper
chromosome segregation and exclusion into MN; whereas global
hypomethylation is associated with more relaxed chromatin,
increased gene expression, elevated DNA damage, and chromoso-
mal breaks which formMNwith acentric chromosome fragments.
Therefore, hypomethylation is related to both aneugenic and
clastogenic mechanisms of MN formation. Nevertheless, such
hypothesis needs further investigation and more experimental
evidences.
DNA in eukaryotes is not naked; it is combined with histone
proteins into chromatin. A relaxed chromatin state is implicated in
numerous biological processes such as replication, transcription,
and repair. Chromatin condensation can become an obstacle for
these processes. Dynamic changes in chromatin structure provide
balanced cellular activities such as proliferation, cell cycle pro-
gression, apoptosis, etc. Uncontrolled chromatin remodeling can
result in dysregulated gene expression and cancer initiation. The
unit of chromatin, termed the nucleosome, consists of four his-
tones: H2A, H2B, H3, and H4. DNA is wrapped around histones,
and a linker histone H1 stabilizes the octamer structure (Ma et al.,
2010). The amino-terminal tails of core histones (25–40 residues)
are not wrapped around DNA but extend into surrounding space
and, therefore, can be targeted by speciﬁc histone modiﬁcators.
The main histone modiﬁcation events known to date are: methy-
lation, acetylation, phosphorylation, and ubiquitination. Histone
modiﬁcations do not cause changes in theDNA sequence, but they
lead to changes in the chromatin state which alters gene expres-
sion (Ma et al., 2010). Histone tails are rich in lysine amino acid
residues which provide a positive charge to histones. Positively
charged histones interact with negatively charged DNA, and a
tight connection betweenDNA and histones is achieved. The pres-
ence of acetylated lysins in histone tails lowers the positive charge
leading to a relaxed chromatin state. An opposite event, deacety-
lation, represses gene expression (Jenuwein and Allis, 2001).
Methylation events in lysine residues cause different chromatin
states, depending on the position at which histone methylation
occurs.
Heterochromatin structure is determined by both CpGmethy-
lation and methylation of histone tails. High levels of methylation
of histone 3 at lysine residue 9 (H3-K4) and low levels of methyla-
tion at H3-K4 are heterochromatin-speciﬁc methylation marks at
the pericentromeric DNA that are controlled by Lsh (lymphoid-
speciﬁc helicase), a member of the SNF2 chromatin remodeling
family. Loss of Lsh results in di- and tri-methylation of H3-K4 in
repetitive sequences (Yan et al., 2003). In addition, Lsh-deﬁcient
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ﬁbroblasts tend to formmultipolar spindles, accumulate high cen-
trosome numbers and last but not least display an increase in
MN formation (Fan et al., 2003). Moreover, the most prevalent
type of acetylation of histones H3 and H4 in embrional ﬁbrob-
last cells derived from Lsh−/− embryos was found in all repetitive
elements such as major and minor satellite sequences and IAP
retroviral-derived sequences (Huang et al., 2004; Muegge, 2005).
These studies indicate the importance of histone modiﬁcations
and chromatin remodeling in chromosome instability and possi-
bly in the formation of MN. Additionally, the two key pioneering
studies have shown the crucial role of altered histone histone
acetylation in MN formation (Qiu et al., 2000; Fujita et al., 2007).
Currently, only a few studies indicate that microRNAs (miR-
NAs) are involved in the induction of MN. miRNAs are known
to regulate gene silencing in mammals, ﬁsh, frogs, insects, worms,
ﬂowers, and viruses. Approximately 2–3% of the human genome
encode for miRNAs (Alvarez-Garcia and Miska, 2005). miRNAs
are important for cellular proliferation, apoptosis, differentiation,
tissue and organ developing. It is now well-known that aberrant
expression of miRNAs is associated with cancer development and
progression. miRNA genes are encoded in cellular DNA and tran-
scribed by RNA polymerase II into large RNA precursors called
pri-miRNAs (500–3000 bases) that are 5′ 7-methylguanosine-
capped and polyadenylated (Liu et al., 2008). In the nucleus,
pri-miRNAs aremicroprocessed byDrosha andPasha (also known
as DiGeorge-syndrome critical region protein 8 – DGCR8). The
products of Drosha and Pasha are ∼70-nucleotide pre-miRNAs
fold into stem-loop structures with a 2-nt 3′ overhang (Lee et al.,
2003; Landthaler et al., 2004). Pre-miRNAs are exported from
the nucleus to the cytoplasm by RAN GTP-dependent exportin
5. In the cytoplasm, pre-miRNAs undergo further processing by
another RNAse III-family/type endonuclease called Dicer (Lee
et al., 2002). Dicer excises an imperfect miRNA duplex from
the pre-miRNA hairpin creating double-stranded RNA of ∼22
nucleotides in length. Such miRNA duplex can be incorporated
into and form the RNA-induced silencing complex (RISC). Dicer
along with the trans-activation response RNA-binding protein
(TRBP), PACT, nuclease Tudor-SN and Argonaute (AGO) pro-
teins contribute to the formation of RISC (Kim et al., 2009). In the
RISC complex, the miRNA duplex is unwounded by speciﬁc heli-
cases to form a single-stranded mature miRNA that is capable to
negatively regulate its target mRNAs. The second strand miRNA
is degraded. MiRNAs with nearly perfect complementarity to the
mRNA sequences induce the RNA-mediated interference (RNAi)
pathway. miRISC binds within the open reading frame (ORF) and
its speciﬁc ribonucleases, mainly Argonaute 2, and cause cleavage
of mRNA, thus resulting in mRNA degradation. This mechanism
is believed to be predominant in plants, but it was also proven to
happen in mammals. However, most animal mRNAs are thought
to be down-regulated rather than cleaved. By this mechanism,
miRNAs bind to the imperfect complementary sequences within
the 3′ untranslated regions (UTRs) of target mRNAs and repress
mRNA gene expression (Stark et al., 2005). In such a way, the levels
of proteins are reduced, but the levels of mRNAs remained stable.
The RISC complex is known to bind active chromatin sites in yeast
and plants, thus causing histone methylation and transcriptional
inactivation.
A recent study of Aypar et al. (2011) showed an immediate
induction of MN following radiation exposure which was paral-
leled with alterations inDNAmethylation andmiRNA expression.
High- and low-linear energy transfer (LET) radiation resulted in
hypomethylation of repeat elements LINE-1 and Alu and the dif-
ferential expression of six (after low LET) and three (after high
LET) miRNAs in human–hamster hybrid cells GM10115. The
identiﬁed targets for thosemiRNAswere involved in the ﬁvemajor
pathways: DNA repair, cell cycle checkpoint, apoptosis, chromatin
remodeling, and DNA methylation. The authors stated that such
epigenetic changes may contribute to radiation-induced genomic
instability. Because MN formation is one of the hallmarks of
genomic instability, miRNA mis-expression may be one of the
mechanisms of MN induction – the hypothesis is waiting to be
tested.
A major class of siRNAs is encoded by repetitive sequences
within heterochromatic regions of centromeres in plants, fungi,
and animals (Ambros et al., 2003; Xie et al., 2004). Such repeat-
associated siRNAs (rasiRNAs) are larger than miRNAs, and their
presence is correlated with a repressed chromatin state (RNA-
induced transcriptional silencing, RITS) of those very regions
from which RNAs are transcribed (Sontheimer and Carthew,
2005). Alterations in the RITS complex of S. pombe led to aberra-
tions in mitosis andmeiosis, such as high rates of non-disjunction
and lagging chromosomes in mitosis and mis-segregation during
meiosis (Hall et al., 2003). The possibility exists that mammalian
rasiRNAs function through a similar pathway for the regulation of
heterochromatin (Holmes and Cohen, 2007).
Overall, centromeres play a key role in cell division being the
sites of kinetochore assemblynecessary for capturingmicrotubules
and pulling the sister chromatids to opposite poles of the spindle.
They are rich in repetitive DNA, heterochromatic, and subject
to epigenetic modiﬁcations. The coordinated epigenetic silencing
of centromeric heterochromatin is essential for maintaining cor-
rect chromosome segregation. Therefore, epigenetic alterations
that lead to a more relaxed chromatin state in centromeres may
directly result in lagging chromosomes and MN formation. Given
a signiﬁcant role of epigenetics in centromere behavior, it is still
not clearly revealed how exactly epigenetic modiﬁcations are asso-
ciated with MN formation. Although the importance of DNA
methylation and chromatin remodeling in centromere behavior
has been shown, the role of RNAi pathways remain obscure. The
summarized roles of both genetic and epigenetic factors in MN
formation are outlined in Figure 5.
THE FATE OF MICRONUCLEI IN CELLS
Analysis of the fate of MN in the cells has recently regained a lot of
interest. The recent study by Utani et al. (2010) suggested thatMN
formed after mitosis were stably maintained in the cells for up to
one cell cycle. Furthermore, mitotic division of cells with MN led
to formation of daughter cells either with or without MN.
The ability of MN DNA to replicate itself remains obscure, but
some suggestions have been made that MN replication depends
onMNnature, and if it happens, usually it occurs at the same time
as main nucleus replication (Obe et al., 1975). Similarly,MN tran-
scription events depend mainly on MN structure. MN containing
whole chromosomes showed active transcription (Labidi et al.,
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FIGURE 5 | Role of the genetic and epigenetic factors in the formation of micronuclei. MN and its components are reﬂected in red, genetic factors are
reﬂected in blue, and epigenetic factors are reﬂected in green.
1987), whereas acentric fragmentswere not able to synthesize RNA
(Hoffelder et al., 2004), unless they represented transcriptionally
competent DMs (Utani et al., 2007). It should be emphasized
here that any possible transcriptional activity in MN depends
on nuclear envelope integrity and the presence of nuclear pore
complexes (NPCs; Geraud et al., 1989; Sukegawa and Blobel,
1993).
The DDR in MN involves the formation of ionizing radiation-
induced foci (IRIF), similar to ones in the main nucleus. γ-H2AX
foci were co-localized with ATM andMDC1 proteins (Medvedeva
et al., 2007). The observation of HR protein Rad51 and ss-
DNA-binding protein RPA in radiation-induced MN leads to the
suggestion that DDR proteins are either randomly entrapped in
MN together with damaged DNA or are recruited to MN that
contain damages (Terradas et al., 2010). Similarly, TP53 accu-
mulation in MN was observed to trigger DDR (Granetto et al.,
1996). Cells treated with colchicine, vinblastine, bleomycin, and
arsenic showed a signiﬁcant induction of MN and p53 (Salazar
et al., 2009). By analogy with DNA replication in MN,DNA repair
may also be compromised by micronuclear envelope trafﬁcking
abilities (Labidi et al., 1987). Multiple studies showed the exis-
tence of apoptotic-like DNA degradation in MN that were unable
to repair DSBs (Terradas et al., 2009). SuchMNi are expulsed from
the cell and are lost forever. The effect of MN expulsion on a cell
can be dual. If destroyed MNi carried extra chromosomes in the
cell, then their elimination would be necessary for regaining the
normal cellular status, but if the MN chromosome was comple-
mentary to the main nucleus, then the cell might lose a certain
gene dosage (Terradas et al., 2010).
Somemicronucleated cells originating from the loss of chromo-
somes can be eliminated by apoptosis. For instance, nocodazole, a
microtubule inhibitor and blocker of cell cycle at M-phase, gives
rise to aneuploid, polyploid, and micronucleated cells. It was
observed that such MN-carrying cells were apoptotically elimi-
nated through the activation of caspase-8, caspase-9, and effector
caspase-3 (Decordier et al., 2008). Interestingly, whenMCF-7 cells
lacking caspase-3 were treated with nocodazole, MN induction
decreased, which allowed the authors to suggest a possible role of
caspase-3 in MN formation (Decordier et al., 2005). There is also
data suggesting the reincorporation of MN into the main nucleus
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and the restoration of normal biological activity in the cell. Alter-
natively, retention of MNwithin the cell as an extra-nuclear entity
is also possible (Leach and Jackson-Cook, 2004).
Micronuclei formation in humans is associated with various
medical conditions. MN in spermatids may lead to infertility,
while a high number of MN in lymphocytes is associated with
pregnancy complications and miscarriages (Fenech, 2011). MN
are one of the four main endpoints, together with chromosomal
aberrations, aneuploidy, and sister chromatid exchange (SCE) in
the identiﬁcation of cancer initiation (Tucker and Preston, 1996;
Hagmar et al., 2001). A large number of papers describe the corre-
lation betweenMNand cancer development. A signiﬁcant increase
in MN in lymphocytes was shown in untreated cancer patients
(Iarmarcovai et al., 2008b). Furthermore, healthy women with
BRCA1 and BRCA2 mutations showed a higher increase in MN
frequency and a higher radiation sensitivity than women without
family history of breast cancer (Rothfuss et al., 2000; Trenz et al.,
2003). Similar outcomes were shown in lung cancer patients with
a high frequency of spontaneous MN (Guler et al., 2005), as well
as in patients with pleural malignant mesothelioma (Bolognesi
et al., 2002), and adenocarcinoma patients (Karaman et al., 2008).
Cancer-prone patients with Bloom syndrome and ataxia telangiec-
tasia also possess a high frequency of MN in lymphocytes (Rosin
and German, 1985). Analysis of European cohorts indicates that
individuals with increasedMN are more likely to get cancer 12–15
years after the test was performed (Bonassi et al., 2007).
MICRONUCLEI AND GENOTOXIC AGENTS
Over the past century, different cytogeneticists have been study-
ing and describing the genotoxic effect of multiple exposures
on cells and organisms, relating such exposures to chromosomal
aberrations, genomic instability, and cancer development (Kirsch-
Volders et al., 2003). The potential of ionizing radiation to directly
or indirectly cause damage to DNA is a good example of such
genotoxic inﬂuence. Different genotoxic agents use a variety of
different mechanisms to alter DNA structure and affect nuclear
integrity (Table 1). For instance, mitotic spindle disrupting agents
cause chromosome malsegregation (Elhajouji et al., 1995), while
metals have a variety of cellular targets (Table 1). Therefore, geno-
toxic agents have been classiﬁed into two classes according to the
mechanism of action: clastogens which cause breaks in chromo-
somes, and aneugens which affect cell division andmitotic spindle
apparatus, leading to aneuploidy. Accordingly, MN formed as a
result of clastogenic or aneugenic treatmentwill differ in their con-
tent. Thus, clastogens and aneugens will form MN with acentric
fragments and whole chromosomes, respectively (Terradas et al.,
2010).
The role of IR in MN production is relatively well understood.
The production of MN in human lymphocytes after X-ray treat-
ment was observed at the time of the ﬁrst mitosis, 48 h after the
culture was started (Countryman and Heddle, 1976). The fre-
quency of MN was much lower when the fractionated dose of
X-rays was applied. Highly energetic beta particles of (90)Sr/(90)Y
caused the induction of MN by an exponential quadratic model
in Chinese hamster ovary (CHO) cells (Murakami et al., 2004).
Similarly, X-rays and UV caused a dose-dependent MN induction
with a slope factor of 1.8 and 10.3 for X-rays and UV, respectively
(Fenech and Neville, 1992). Cytogenetic results of IR-exposed
individuals in the Southern Ural showed a higher frequency of
MN in lymphocytes and a lower adaptive response, compared to
Moscowpeople (Akleev et al., 2002). In their study, Kamiguchi and
Tateno (2002), evaluated MN as markers of chromosomal aberra-
tions in human and hamster and mouse spermatozoa irradiated
in vitro by ﬁve kinds of ionizing radiation (137C gamma, 60Co
gamma, X-rays, 3H beta, and 252Cf neutrons). Radiosensitivity
measured by the MN test was the highest in human spermatozoa,
followed by hamster and mouse cells. The authors emphasized
the importance of sperm chromosome analysis for cancer patients
treated with radiotherapy (Kamiguchi and Tateno, 2002). Dif-
ferent results were described for X-irradiated human and canine
lymphocytes. MN yield in canine cells after 1 and 2 Gy was about
1.3 times higher than in human cells. Such a differencemay be due
to a different chromosome number in dogs and humans (78 and
46 chromosomes, respectively; Catena et al., 1994).
Table 1 | Role of selected genotoxic agents in micronuclei formation.
Ionizing radiation Anti-mitotic agents
(vinca alkaloids)
Metals DNA methylating agents Anthracycline drugs
DNA and protein
adducts, DNA strand
breaks, crosslinks,
gene mutations
Mitotic spindle
disruption, chromosome
malsegregation
By binding to DNA and proteins
cause damage to DNA, altered
gene expression, mutations,
altered cell cycle, chromosome
non-disjunction, cytoskeleton
dysfunction
Loss of methylation in centromeric
and paracentromeric regions, sister
chromatid decondensation,
improper chromosome segregation,
chromosome breaks
DNA damages, disruption of
DNA replication and DNA
repair, DNA breaks
Mainly clastogenic
effect, but mutations
in certain cell cycle
and repair genes may
cause aneugenic MN
Mainly aneugenic Both clastogenic and aneugenic
effects, depending on the metal
Aneugenic, if hypomethylation in
centromeric regions; clastogenic if
global hypomethylation leading to
DNA strand breaks
Mainly clastogenic
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The combination of ionizing radiation and certain chemical
compounds or drugs can result in an absolutely different response
compared to that caused by IR or drug alone. For instance,
X-rays increase the frequency of micronucleated polychromatic
erythrocytes (MNPCE) in mice in a similar way to the S-2-/
3-aminopropylamino/ethyl phosphorothioic acid (WR-2721). If
WR-2721 was administered before IR, the frequency of MN was
reduced, showing the protective effect of the drug on IR tox-
icity (Mazur, 1995). In contrast, 3-aminobenzamide increased
the IR-induced MN in human lymphocytes (Catena et al., 1992).
Supra-additivity by 34–86%,was described for the combination of
gamma-IR and ethyl methanesulfonate in mouse lymphoma cells
(Stopper et al., 2000). Finally, the combination of doxorubicin
and gamma-radiation increased the frequency of MN and death
rates in HeLa cells; thus, it allowed authors to make a conclusion
that combinational treatment increases the genotoxic effect of the
either treatment given alone (Jagetia and Nayak, 2000).
Micronuclei testing is widely used for the evaluation of geno-
toxicity of different anti-cancer drugs. Adriamycin is an anthra-
cycline drug with strong mutagenic properties that increases MN
incidence up to 10- to 15-fold and signiﬁcantly declines cell sur-
vival (Bhuyan et al., 1983; Jagetia and Nayak, 2000). Curcumin
alone induces MN in PC12 cells but reduces the total frequency
of MN induced by cisplatin, thus showing both genotoxic and
antigenotoxic properties, depending on prescription protocols
(Mendonca et al., 2009). Similarly, anti-cancer drugs, gemcitabine
and topotecan, increase abnormal metaphases and the number of
MN in mouse bone marrow (Aydemir and Bilaloglu, 2003). The
CBMNassay showed the stimulation of DNAdamages inV79Chi-
nese hamster cells after combinational treatment with bleomycin
and DNA-PK inhibitor wortmannin (Oliveira et al., 2002).
Vindesine, an anti-mitotic vinca alkaloid, if combined with
gamma-radiation, reduces survival of V79 cells by increasing
the frequency of MN (Jagetia and Adiga, 2000). MN caused by
breakage events were noticed in human lymphocytes treated with
antineoplastic drug ASE (Andrianopoulos et al., 2000). Tenipo-
side, an anti-tumor drug used for treatment of childhood acute
lymphocytic leukemia, inducedMNwith a peak frequency at 16 h
after treatment, which was correlated with cell survival decline
(Adiga and Jagetia, 1999). An interesting genotoxic mechanism
of action of natural alkaloids of pyrido-thiazolo-acridine series
was observed; acridines acted through the DNA-intercalating
mechanism in the dark, but DNA-adducts were formed after
photo-activation (Di Giorgio et al., 2008). Last but not least,
methylating agents, MMS and N-methyl-N-nitrosourea (MNU),
generated a linear dose response in MN formation (Lutz et al.,
2005).
While MN formation is the wanted result caused by tested
anti-cancer drugs, it is a less desirable endpoint in testing of mul-
tiple drugs used to treat a variety of diseases other than cancer.
Thus, MN induced by such treatments are considered to be a side
effect of drug action. One example is the cytogenetic toxicity of
metronidazole (a commonRosacea treatment agent) which causes
MN induction in somatic cells of mature male Swiss mice and
is correlated with anemia development and decreased male fer-
tility (el-Nahas and el-Ashmawy, 2004). MN evaluation among
79 renal transplant patients showed that immunosuppressive
therapy induces mutagenic side effects resulting in chronic renal
failure (Rath and Oliveira-Frick, 2009). Acyclovir, the most com-
mon agent to treat cold sores, was shown to enhance radiation
effects on MN formation in HeLa cells, although it does not
demonstrate a possible side effect of the drug during its spe-
ciﬁc treatment (Jagetia and Aruna, 2000). An anti-leukemic drug,
Myleran (R), caused MN in rat lens epithelial cells, thus proving
the hypothesis about cataractogenicity of certain drugs (Odrich
et al., 1988). Similarly, AIDS treatment with nucleoside analogs
increasedMN in bonemarrow, which suggests that intrinsic geno-
toxic activity of nucleoside analogs should be considered during
selectionof drug administration forAIDS treatment (Phillips et al.,
1991).
A series of studies indicate similar results in terms of geno-
toxic potential and MN induction for: Strychnos pseudoquina, a
Brazilian medicinal plant with novel antiulcerogenic activity, that
was shown to give rise to MN in blood cells (Santos et al., 2006),
West African plant Cryptolepis sanguinolenta which contains an
anti-malarial herbal alkaloid, cryptolepine, that induces MN in
hamster ﬁbroblast cells (Ansah et al., 2005), anti-obesity drugs
sibutramine and fenproporex that induce MN in Swiss mice (da
Silva et al., 2010), and some antibacterial/antiviral drugs possess-
ing clastogenic and aneugenic properties (Abou-Eisha et al., 2004;
Balakrishnan and Eastmond, 2006; Nersesyan et al., 2011).
Genotoxicity of the environment and manufactory pollution
has always been an important issue (Buchet et al., 1995; Ibrulj et al.,
2006). In their study, Neri et al. (2003) described the effect of vari-
ous environmental mutagens on the frequency of MN in children
(0–18 years). A higher sensitivity to pollution and a minor role
of cigarettes smoking and lifestyle makes children a better model
population for environmental cytogenetic monitoring. Common
genotoxic agents, such as ionizing radiation, air pollution, and
chemical drugs, cause an increase in MN frequency in children
(Neri et al., 2003).
Hornhardt et al. (2006) showed that the combination of arsenic
trioxide in the concentration close to that occurring in nature
induces MN in human lymphoblastoid cells if combined with
gamma-radiation. Similar observations were made for genotoxic-
ity of chelate complexes of mercury (II) employed in detoxiﬁcation
of some polluted areas. The complex of mercury (II) with EDTA
interferes with tubulin assembly in V79 cells (Stoiber et al., 2004).
The insecticide lindane increases the number of MN up to ﬁve-
fold in MCF-7 breast and PC-3 prostate cells 24 h post-treatment
(Kalantzi et al., 2004), while four commercial pesticides used in
Italian agriculture induce genotoxic damage only if used in high
toxic doses. These were Citroxin (CX), Decis (DS), Tramat Combi
(TC), and Lasso Micromix (LM), containing following agents –
Alachlor (in LM), Clopyralid (in CX), Ethofumesate and Lenacil
(in TC), and Deltamethrin (in DS; De Marco et al., 2000). In a
series of studies, Dorn et al., 2008a,b, evaluated clastogenic and
aneugenic effects of various anabolic steroids misused by athletes
in sports. Most of these steroids induced MN in V79 cells up to
2-fold compared with controls, thus, presenting a potential geno-
toxic hazard (Dorn et al., 2008a,b). The potential hazards of dental
adhesives interactingwith pulp tissues can also be expected. Dental
adhesives cause the generation of ROS contributing toMN forma-
tion up to 6-fold in V79 cells (Demirci et al., 2008). MN tests also
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conﬁrm a slight genotoxic potential of the common ingredient of
oxidative hair dyes, p-phenylenediamine (PPD), in vitro, but not
in vivo (Garrigue et al., 2006).
Continuing to discuss genotoxicity, it should be mentioned,
that aspartame, a low-calorie sweetener, can bemutagenic andmay
cause chromosome aberrations and MN (Rencuzogullari et al.,
2004). On the other hand, genotoxicity of human breast milk
is unexpected. Samples of human milk of healthy nursing moth-
ers were positive in bacterial tests for mutagenicity (Ames test)
and in tests for clastogenicity (MN test). Human milk extracts
induced MN in MCL-5 (human lymphoblastoid cells), while cells
treated with cow’s milk and corn oil were MN negative (Martin
et al., 1999). In the same manner, soy isoﬂavones in human diet
were used for studies of chromosomal genotoxicity. It was shown
that isoﬂavone genistein caused a dose-related formation of MN
in a dose range of 5–25 μM in V79 cells. Most of the MN did not
contain kinetochores, indicating the clastogenic mode of action of
genistein (Di Virgilio et al., 2004). A dose-dependent MN forma-
tion was discovered in ovine seminal vesicle (OSV) cell cultures
treatedwith ochratoxinA (toxin produced byAspergillus and some
Penicillium species) found in common foods. The majority (70%)
of MN was kinetochore-positive, pointing to an aneugenic effect
of ochratoxin (Degen et al., 1997).
Because genotoxicity is linked to chromosome aberrations, it
is expected that cigarette smoking would cause MN. Surpris-
ingly, most studies deny the ability of smoking compounds to
induce MN. In the Human MicroNucleus project, 1409 cur-
rent smokers and 800 former smokers were tested for MN in
lymphocytes. Both groups showed a decrease in MN frequency
compared to non-smokers (Bonassi et al., 2003). Although, when
tobacco-speciﬁc nitrosamine (NNK) was added to the culture of
the repair-deﬁcient ﬁbroblasts, the frequency of MN was doubled
(Pohlmann et al., 1992) suggesting that smoking could induceMN
in repair-deﬁcient cells.
Multiple studies describe kinetics of MN induction by differ-
ent genotoxic agents (Przybojewska, 1992). For instance, some
vinca alkaloids block cell division immediately, while vinblastine
and vincristine cause a delay after exposure, although produc-
ing a higher maximal velocity (Morales-Ramirez et al., 2004).
The induction of MN by colchicine also occurs rapidly; MNPCE
appeared in blood stream almost at the same time as after expo-
sure to gamma-rays (Vallarino-Kelly andMorales-Ramirez, 2001).
A long latency period inMN formationwas observed aftermethyl-
nitrosourea, thus proving that the agent causes DNA breaks
through the repair of mismatches induced during a previous
division. Therefore, a relationship exists between the kinetics of
MN and chromosomal break formation (Morales-Ramirez and
Vallarino-Kelly, 1999).
ANTICLASTOGENIC AGENTS AND MICRONUCLEI
Considering a growing number of genotoxic agents, anti-
mutagenic properties of some compounds are of great value (Raj
et al., 2001). According to Heo et al. (1992), most ﬂavonoids pos-
sess anticlastogenic properties. The authors tested 14 ﬂavonoids
against the induction of MN by benzo[a]pyrene in polychro-
matic lymphocytes in mice. All of them showed a dose-dependent
decrease in MN induction by benzo[a]pyrene (Heo et al., 1992).
Similarly, ﬂavonol galangin showed the anti-mutagenic (Ames
test) and anticlastogenic (MN test) capability against N-methyl-
N-nitrosourea in mouse bone marrow cells and, therefore, may
be a useful chemopreventive agent (Sohn et al., 1998). Free radical
scavenging properties of naringin, a grapefruit ﬂavanone, signif-
icantly reduced the amount of damages and MN in bleomycin-
treated V79 cells (Jagetia et al., 2007). The other study by Choy
et al. (1995) described the inhibition of urethane-induced MN
by ethanol. Urethane is a mutagenic carcinogen that is found
in fermented products and alcoholic beverages. Ethanol can
inhibit certain pathways in the production of cytotoxic metabo-
lites of urethane. The co-administration of urethane and ethanol
in bone marrow polychromatic erythrocytes decreases MN fre-
quency with an ethanol dose of 2500 mg/kg and above (Choy
et al., 1995). A therapeutic drug cimetidine has been shown
to protect bone marrow cells from radiation- and benzene-
induced MN, most probably by free radical scavenging and
the activation of the glutathione system along with cytochrome
P450 inhibition (Mozdarani and Kamali, 1998). Another drug,
fullerenol, decreased the frequency of MN in CHO-K1 cells
due to its antioxidative properties (Mrdanovic et al., 2009). As
expected, vitamin E prevents 30–50% of the toxic effect of
zearalenone (non-steroidal mycotoxin), mainly by acting either
as ZEN structural analog or as an antioxidant (Ouanes et al.,
2003).
An interesting study showed an anticlastogenic effect of Ginkgo
biloba extract (EGb 761) on patients with a hyperthyroid Grave’s
disease. Such patients were treated with radioiodine therapy
which causes chromosomal damages in the form of MN. The
supplementation with EGb 761 during radioiodine treatment
neutralized genotoxic effects without interfering with clinical
outcomes (Dardano et al., 2007).
Finally, a surprisingly optimistic study described anti-
carcinogenic effects of beer on aberrant crypt foci in the rat colon.
Four commercial beers such as two Pilsner-type, black and stout
showed inhibitory effects on heterocyclic amine-induced muta-
genesis. Freeze-dried samples of pilsner and stout beer reduced
the number of micronucleated cells, suggesting that beer inhibits
genotoxic affects of heterocyclic amines and reduces the risk of
carcinogenesis (Nozawa et al., 2004).
THE FREQUENCY OF MICRONUCLEI FORMATION: LIFESTYLE
FACTORS AND GENETIC POLYMORPHISMS
Different variants may modulate the effect of genotoxic agents on
MN frequency. Mainly, they are host factors (age, gender), lifestyle
(smoking, alcohol, occupation, folate, and vitamins intake), and
disease susceptibility (cancer, etc.; Iarmarcovai et al., 2008a). Over
the last century, multiple studies on MN formation have been
described. Theprospective analysis of suchdata shows the variabil-
ity in MN frequency depending on the above-mentioned factors.
Intra- and interindividual characteristics seem to account for MN
formation. A comparison of three different mouse strains showed
different sensitivity to the induction of MNPCEs by the same
clastogenic effects (Sato et al., 1990).
Bolognesi et al. (1997) described an age-related increase in
chromosome damages and MN formation in lymphocytes. Anal-
ysis of population data from 12 Italian laboratories in the mid
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1980s–1990s showed the most dramatic increase in MN in the age
group of 50–59 that remained unchanged thereafter (Bolognesi
et al., 1997). The age-associated incline in CA and MN may be
caused by a decline in DNA repair (Hanawalt et al., 1992) and the
aneuploidy phenomenon (Richard et al., 1993). Genomic insta-
bility and oncogenicity cause the accumulation of DNA damage
with age. Oxidative damage can also contribute to MN frequency
during ageing (Ames and Shigenaga, 1992). The baseline MN fre-
quency in newborns and children is relatively low, but higher
susceptibility to DNA damages in children may rapidly increase
the MN formation due to environmental exposure to genotoxic
agents (Holland et al., 2011). Gender factors have been stud-
ied in parallel with aging. Mainly, a higher MN frequency has
been reported for women (Barale et al., 1998). Similarly, the
effect of gender was described for MN associated with aneu-
ploidy (centromere-positive MN), which was higher in females
(Iarmarcovai et al., 2007a). The frequency of X chromosome
loss was also shown to be higher in females, especially in older
women with X chromosome loss of approximately 22% (Bukvic
et al., 2001). The impact of alcohol consumption on MN for-
mation was also observed (Iarmarcovai et al., 2007a). The effect
of smoking correlated linearly with chromosomal aberrations
such as sister chromatid exchanges (Barale et al., 1998), and it
surprisingly had no inﬂuence on MN formation (Bukvic et al.,
2001).
Genetic polymorphisms have the major inﬂuence on interindi-
vidual susceptibility to MN formation (Iarmarcovai et al., 2007b).
Single nucleotide polymorphisms in DNA repair genes XRCC1,
XRCC3, and XPD (xeroderma pigmentosum group D) increased
MN frequencies in radiological workers exposed to low levels
of ionizing radiation compared to control individuals of the
same genotype (Angelini et al., 2005). Similarly, glutathione S-
transferase M1 polymorphisms inﬂuenced MN induction in coke
oven workers, smokers, and subjects living in polluted areas
(Sram, 1998). ALDH2 (aldehyde dehydrogenase 2) polymorphism
is also associatedwithMN formation induced by alcohol (Ishikawa
et al., 2003). For instance, ALDH2*2, an inactive variant allele of
ALDH2, is highly present among Asian populations.
An individual predisposition to diseases, such as cancer, is cor-
related with MN incidence. MTHFR (methylenetetrahydrofolate
reductase) variants involved in folate metabolism may develop
into coronary artery disease (Andreassi et al., 2003). Asmentioned
previously, folate deﬁciency is often associated with an increase
in the MN frequencies. Carriers of BRCA1 and BRCA2 muta-
tions are predisposed to enhanced sensitivity to DNA damage,
MN formation, and cancer development (Speit and Trenz, 2004).
Recently, van Leeuwen et al. (2011) developed a transcriptomic
network analysis of MN-related genes based on the knowledge
from literature and a case study on children and adults who were
differentially exposed to air pollution. Using a pathway tool Meta-
Core, the authors retrieved 27 genes and gene complexes involved
in MN formation. Such genes were mainly associated with cell
cycle checkpoints, spindle assembly, and aneuploidy. The network
was tested against a gene expression case study of individuals
living in highly polluted mining area of Teplice (TP) in Czech
Republic and less polluted area of Prachatice (PR) in the same
country. Six genes from the network were retrieved in the exposed
group where they were differentially expressed: BAX, PCNA, p21,
CDC20, DNMT1, and HIC1. These genes were combined with
p53 and IL-6 to create amicronucleus network (van Leeuwen et al.,
2011). This study provided a novel,mechanistically relevant infor-
mation on population response to genotoxic agents in relation to
MN formation.
Further investigation may reveal novel genes which can be
added to the network. Transcriptomic data may be incorporated
in a future prediction and screening of genotoxic effects on MN,
genomic instability, and cancer initiation.
CONCLUSION
Due to their rapid formation and easy detection,MNhave become
the most prevalent biomarker of chromosomal defects induced by
genotoxic agents. A variety of clastogenic and aneugenic toxins
have been tested in different cells and tissues, using the MN test
as one of the endpoints. The ability to distinguish between chro-
mosome fragments and whole chromosomes lagging behind in
anaphase allows the determination of the mechanisms of action
of a variety of mutagenic agents. In the last decades, an enormous
amount of data has shed light on the mode of MN formation,MN
incidence in different cells and tissues among individuals, and the
fate of MN in cells damaged by genotoxins. MNi are thought to
reﬂect the initial stage in the development of genomic instability
and tumorigenesis. Individuals predisposed to cancer tend to form
MNmore rapidly than persons without hereditary history. There-
fore, MN screening may serve as a valuable method in predicting
various diseases, including cancer. Cancer treatment therapies also
rely on the ability to cause profound damage and induce death in
malignant cells. The formation of MN in cancer cells undergoing
new treatment indicates the activity and speciﬁcity of the tested
therapy. On the other hand, common drugs may cause side effects
if the MN induction in non-target cells is observed. Biomoni-
toring studies aimed to understand the effect of environment on
populations with different lifestyles and sensitivity to genotox-
ins are of a great value. The transcriptome network reﬂecting
genes associated with MN formation may help to better under-
stand the value of chromosome damages induced by surrounding
genotoxins.
AlthoughMN studies are the leading ﬁeld inmutation research,
some important knowledge gaps remain uncovered. Namely, it is
not fully addressed whetherMN re-engulfed by the cell can restore
a complete genotype in the cell, and whether MN can contribute
to cellular gene expression. The exact mechanism of MN content
degradation is also under question. Better understanding of gene
interactions responsible for different MN frequencies would help
to improve drug testing, biomonitoring of diseases and the predic-
tion of the effects of common genotoxic agents. Moreover, more
studies are needed to understand the role of epigenetic factors in
MN formation.
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